Edwards Lifesciences Files 8-K
Ticker: EW · Form: 8-K · Filed: Aug 19, 2025 · CIK: 1099800
| Field | Detail |
|---|---|
| Company | Edwards Lifesciences Corp (EW) |
| Form Type | 8-K |
| Filed Date | Aug 19, 2025 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $1.00 |
| Sentiment | neutral |
Sentiment: neutral
Topics: sec-filing, 8-k
Related Tickers: EW
TL;DR
EDWARDS files 8-K, check for updates.
AI Summary
Edwards Lifesciences Corporation filed an 8-K on August 19, 2025, reporting other events and financial statements/exhibits. The filing does not contain specific details on new events or financial figures within the provided text.
Why It Matters
This filing indicates a routine update or disclosure from Edwards Lifesciences to the SEC, which may contain important information for investors.
Risk Assessment
Risk Level: low — The filing is a standard 8-K report without immediate indication of significant negative events.
Key Players & Entities
- Edwards Lifesciences Corporation (company) — Registrant
- August 19, 2025 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of incorporation
- 001-15525 (other) — Commission file number
- 36-4316614 (other) — IRS Employer Identification No.
- One Edwards Way Irvine, California 92614 (address) — Address of principal executive offices
- 949-250-2500 (phone_number) — Registrant's telephone number
FAQ
What specific 'Other Events' are being reported in this 8-K filing?
The provided text for the 8-K filing does not specify the details of the 'Other Events' being reported.
What is the purpose of filing an 8-K report?
An 8-K report is filed to announce major corporate events that shareholders should know about, such as acquisitions, bankruptcies, or changes in executive management.
When was Edwards Lifesciences Corporation incorporated?
Edwards Lifesciences Corporation was incorporated in Delaware.
What is the principal executive office address for Edwards Lifesciences?
The principal executive office is located at One Edwards Way, Irvine, California 92614.
What is the filing date for this 8-K report?
The filing date, and the date of the earliest event reported, is August 19, 2025.
Filing Stats: 456 words · 2 min read · ~2 pages · Grade level 10.9 · Accepted 2025-08-19 16:17:08
Key Financial Figures
- $1.00 — ich registered Common Stock, par value $1.00 per share EW New York Stock Exchange
Filing Documents
- ew-20250819.htm (8-K) — 29KB
- a8-kxexhibitpressrelease.htm (EX-99) — 9KB
- image_0a.jpg (GRAPHIC) — 32KB
- 0001099800-25-000056.txt ( ) — 197KB
- ew-20250819.xsd (EX-101.SCH) — 2KB
- ew-20250819_lab.xml (EX-101.LAB) — 21KB
- ew-20250819_pre.xml (EX-101.PRE) — 12KB
- ew-20250819_htm.xml (XML) — 3KB
01. Other Events
Item 8.01. Other Events. On August 19, 2025, Edwards Lifesciences Corporation a Delaware corporation, issued a press release announcing its entry into an accelerated share repurchase agreement. A copy of the press release is filed as Exhibit 99.1, and is incorporated herein by reference. Item9.01. Financial Statements and Exhibits. (d) Exhibits 99.1 Press Release, issued on August 19, 2025, announcing Accelerated Share Repurchase Agreement. 104 Cover Page Interactive Data File (embedded within the Inline XBRL document). 2
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. EDWARDS LIFESCIENCES CORPORATION By: /s/ Scott B. Ullem Scott B. Ullem Date: August 19, 2025 Chief Financial Officer 3 Exhibit Index Exhibit Number Description 99.1 Press Release, issued on August 19, 2025, announcing Accelerated Share Repurchase Agreement. 104 Cover Page Interactive Data File (embedded within the Inline XBRL document). 4